Skip to content
ClinCalc Pro
Menu
Bile Acid Sequestrant / Ion Exchange Resin

Colestyramine (Cholestyramine)

Brand names: Questran

Colestyramine (cholestyramine) is an oral anion-exchange bile-acid sequestrant used for bile-acid diarrhoea, pruritus associated with cholestasis or partial biliary obstruction, and as a lipid-lowering agent.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds bile acids in the gut to form an insoluble complex that is excreted in the faeces, interrupting enterohepatic recirculation and increasing hepatic conversion of cholesterol to bile acids.

Prescribing in practice

  • It binds many other drugs in the gut and reduces their absorption, so administer other medicines well before or after it, and be aware it can impair absorption of fat-soluble vitamins on prolonged use.
  • Constipation is common and it should be avoided in complete biliary obstruction, where it is ineffective.
  • Prolonged use may warrant supplementation of fat-soluble vitamins, particularly in children or with high doses.

Monitoring

Monitor lipids where used for hyperlipidaemia and consider fat-soluble vitamin status with prolonged therapy.

Counselling the patient

  • Mix the powder thoroughly with water or a suitable liquid before taking, as directed.
  • Take your other medicines at a separate time, at least an hour before or several hours after this one.
  • Tell your prescriber if you become constipated.

Evidence & guidelines

Established prescribing references support colestyramine for bile-acid diarrhoea and cholestatic pruritus, and its propensity to bind co-administered drugs is a well-recognised interaction.

Reference: NICE CG149 Jaundice in Adults; SeHCAT Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.